Search Results 131-140 of 10133 for SC
... SC, Oberg AL, Larson MC, Atkinson HJ, Duffield LN, Peterson KL, Kaufmann SH, Weroha SJ. Antitumor activity of rucaparib plus PLX038A in serous endometrial ...
The research team was led by James Naessens, Sc.D., a health care policy researcher at Mayo Clinic. Why get a second opinion. When people are sick, they look ...
The purpose of the study is to demonstrate the efficacy and safety, and to assess the pharmacokinetics of adalimumab administered subcutaneously (SC) in ...
... SC and was on staff at University of South Carolina. Previously, he was on faculty at University of Minnesota working as a hospitalist in community and ...
... SC, Paulson L, Clark-Swanson K, Lassiter-Morris Y, Smith KA, Nakaji P, Bendok BR, Zimmerman RS, Krishna C, Patra DP, Patel NP, Lyons M, Neal M, Donev K ...
It often affects the ovaries, fallopian tubes and the tissue lining the pelvis. Rarely, endometriosis growths may be found beyond the area where pelvic organs ...
Dyson School of Applied Economics and Management, SC Johson College of Business, Cornell University. 2019. FellowRST Musculoskeletal Imaging, Programs in ...
Learn how this imaging scan can play an important role in early detection of health problems, such as cancer, heart disease and brain disorders.
... SC, National Heart, Lung, and Blood Institute (NHLBI) Severe Asthma Research Program and TOPMed mtDNA Working Group in NHLBI Trans-omics for Precision ...
The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) ... Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.